Helping Life Sciences Organizations Reach More Patients

International Marketing Solutions for the Life Sciences Industry

Get a Free Consult
Dark purple lab drip

Targeted Patient Campaigns for Anywhere in the World, in Any Language

  1. Roughly 80% of clinical trials fail to meet enrollment timelines.
  2. Approximately one-third (30%) of Phase III study terminations are due to enrollment difficulties.
  3. As these statistics make abundantly clear, better patient recruitment processes can drastically improve clinical trial success.

Create Strategic Global Patient Recruitment Campaigns

We can help with our extensive market research, global expertise, and local digital marketing experts

  • Market Insights – Mapping the Patient Journey
  • Cultural Consulting – Adapting Content for Intended Audiences
  • Regulatory Consulting – Advising on Local Regulations (e.g., Promotional Liability in the EU)
  • Medical Writing & Content Development
  • Digital Strategy
  • Translation and Media
  • Technology to Streamline Approval Process

Benefits of TransPerfect's Digital Patient Engagement Solutions

Patient recruitment consumes 27% of the cost of development–that is $5.9 billion annually around the world.

  • Icon Timelines

Shrink Timelines for Creating and Launching Campaigns

  • Icon Save Money

Save Money on Campaign Planning and Execution

  • Icon Marketing

Retain More Patients with Improved Targeting and Patient Education

  • Icon Regulatory

Maintain Protocol Adherence and Reduce Compliance Risks

Streamline Patient Recruitment Strategies

A diverse and inclusive patient recruitment strategy is key to ensuring a successful clinical trial. TransPerfect Life Sciences supports pharmaceutical companies in reaching patients, meeting enrollment numbers, and meeting diversity and inclusion goals. With extensive market research and global expertise, our local digital marketing experts develop strategic recruitment marketing plans and messaging that engage patients across all channels.

Trusted by Life Sciences Organizations Big and Small

Join TransPerfect's community of over 1,000 life sciences organizations, including pharma, biotech, CROs, IRBs, and agencies.

20230124-lifesciences-resize-v3_0022_400x160px-hologic_logo.png
untitled_design_4.png
20230124-lifesciences-resize-v3_0016_400x160px-bayer_logo.png
20230124-lifesciences-resize-v3_0015_400x160px-merck_logo.png

Ready to Reach More Patients?

Schedule a free consult.

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

News and Thought Leadership

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations.

AI and Medical Device Regulations: Why Human Experts Still Sign Off

In our previous post, we covered the EUDAMED deadline for SSCPs and SSPs, which came up again and again at the RAPS Convergence Conference in Charlotte, North Carolina. In this post, we’re diving into another theme that was just as hard to miss: what AI means for the people who do regulatory work. That was the subject of an overflow session titled “How Is AI Affecting the Regulatory Workforce?” The question behind most of the discussion: Will AI take our jobs? The ...

AI and Medical Device Regulations: Why Human Experts Still Sign Off

How to Select the Right Regulatory Writing Company for Your Organization's Needs

In a landscape defined by ever-evolving global guidelines from health authorities, many life sciences organizations’ clinical and regulatory teams face challenges in navigating the regulatory affairs writing and document submission process. Adhering to strict rules while...

LifeSci Talks COA Series | Clinical Trial Site Burden: Why One Study Can Mean Up to 15 Systems

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Kees van Ooik, Vice President of Clinical Technologies at Almac Clinical Technologies, to talk about the burden clinical trial sites face when one study runs on up to ...

Governing AI for Global Content in the Life Sciences Industry

AI is already shaping the content that reaches patients, healthcare professionals, and regulators, often through tools that were never built for regulated use. But adoption alone doesn’t create control, and a single terminology error or untraceable approval can put compliance and ...

MDR SSCPs and IVDR SSPs Are NOT Labeling: What That Means for Your EUDAMED Upload

As soon as possible, but no later than March 27, 2027 (per MDCG 2026-4), medical device manufacturers must upload their validated, translated Summaries of Safety and Clinical Performance (SSCPs) to EUDAMED themselves. IVD manufacturers have the same responsibility for their...

Reddit Stories: AI Failures in Clinical Trials

Clinical operations experts react to real AI failure stories pulled directly from Reddit and work backward to identify what should have caught them. From hallucinated citations that passed an initial review to AI-drafted guidance sent to a site without proper oversight, each ...

Are Legacy COA Instruments Still Fit for Purpose?

The following insights are synthesized from TransPerfect LifeSci Talks, hosted by Mark P. Wade, Practice Leader COA SME at TransPerfect Life Sciences, with guest Kathrin Fischer, PhD, Patient-Centered Outcome Strategy Lead at Boehringer Ingelheim and board member of ISOQOL....